CAMG
JAZZ icon

CWA Asset Management Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

CWA Asset Management Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.73M Buy
19,619
+109
+0.6% +$23.9K 0.14% 152
2026
Q1 		$3.69M Sell
19,510
-1,232
-6% -$215K 0.13% 174
2025
Q4 		$3.53M Sell
20,742
-1,035
-5% -$159K 0.13% 156
2025
Q3 		$2.87M Sell
21,777
-358
-2% -$42.9K 0.11% 175
2025
Q2 		$2.35M Sell
22,135
-1,507
-6% -$164K 0.1% 186
2025
Q1 		$2.94M Sell
23,642
-2,963
-11% -$387K 0.14% 142
2024
Q4 		$3.28M Sell
26,605
-2,088
-7% -$246K 0.17% 121
2024
Q3 		$3.2M Buy
+28,693
New +$3.14M 0.17% 115
2024
Q1 		$3.57M Buy
+29,651
New +$3.63M 0.22% 101

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
OLA
Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return

CWA Asset Management Group's JAZZ Position: Q2 2026 in Review

CWA Asset Management Group increased its Jazz Pharmaceuticals (JAZZ) stake by 0.56% in Q2 2026, buying an estimated $23.9K and bringing the position to 19,619 shares worth $4.73M. The position accounts for 0.14% of the portfolio, ranked #152.

CWA Asset Management Group first reported a position in JAZZ in Q1 2024 and has held it in 9 quarters since. 69 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • CWA Asset Management Group held 19,619 shares of Jazz Pharmaceuticals worth $4.73M as of Q2 2026.
  • CWA Asset Management Group bought 109 Jazz Pharmaceuticals shares in Q2 2026, an estimated $23.9K.
  • Jazz Pharmaceuticals made up 0.14% of CWA Asset Management Group's portfolio in Q2 2026, its #152 holding.
  • CWA Asset Management Group first reported a position in Jazz Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • 69 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.